BlackRock Fund Advisors’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$11.6M Buy
713,006
+535,677
+302% +$8.13M ﹤0.01% 2494
2016
Q3
$2.39M Buy
177,329
+13,944
+9% +$286K ﹤0.01% 3118
2016
Q2
$3.99M Buy
163,385
+4,466
+3% +$151K ﹤0.01% 2932
2016
Q1
$5.49M Buy
+158,919
New +$4.18M ﹤0.01% 2693

Other funds holding EDIT

BlackRock Fund Advisors's EDIT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Editas Medicine (EDIT) stake by 302% in Q4 2016, buying an estimated $8.13M and bringing the position to 713,006 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

BlackRock Fund Advisors first reported a position in EDIT in Q1 2016 and has held it in 4 quarters since. 84 funds tracked by Wall St. Rank hold EDIT as of Q4 2016.

  • BlackRock Fund Advisors held 713,006 shares of Editas Medicine worth $11.6M as of Q4 2016.
  • BlackRock Fund Advisors bought 535,677 Editas Medicine shares in Q4 2016, an estimated $8.13M.
  • Editas Medicine made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2494 holding.
  • BlackRock Fund Advisors first reported a position in Editas Medicine in Q1 2016 and has held it in 4 quarters since.
  • 84 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.